孕產婦心理健康市場－全球產業規模、佔有率、趨勢、機會、預測：按疾病、治療方法、地區和競爭格局分類，2021-2031年

全球孕產婦心理健康市場預計將從 2025 年的 59.7 億美元成長到 2031 年的 105.7 億美元，複合年成長率為 9.99%。

該市場涵蓋多種診斷、治療和支援服務，旨在預防、檢測和管理懷孕及產後心理健康問題。推動這一市場成長的關鍵因素包括：公眾和醫療保健專業人員對孕產婦心理健康的認知不斷提高，對孕產婦健康對兒童發育影響的理解日益加深，以及全球產後憂鬱症和焦慮症盛行率的上升。世界衛生組織（世衛組織）在2023年報告中指出，全球約有10%的孕婦和13%的產後母親會經歷某種形式的心理健康問題，其中以憂鬱症最為常見。

阻礙市場擴張的一大障礙是全球範圍內，尤其是服務不足地區，持續存在的母嬰心理健康專業人員短缺問題。合格人員的匱乏可能會限制患者及時獲得適當治療，從而阻礙基本心理健康服務和介入措施的廣泛部署和利用。

市場促進因素

政府的資金投入和優惠政策正透過建立專門的基礎設施和擴大服務覆蓋範圍，大力推動全球孕產婦心理健康市場的發展。這些公共部門的努力通常轉化為直接的財政支持，促進了重要治療網路的壯大。例如，英國皇家助產士學院在2025年2月指出，已撥款3,650萬英鎊用於加強英國的家庭心理健康支持。這筆資金來自2025年至2026年期間國家層級增加的1.26億英鎊撥款。這些投資將有助於創建和擴展專門的孕產婦心理健康計畫、專業培訓和定期篩檢計畫。此外，政策還透過強制性保險覆蓋和推廣綜合護理系統來刺激市場發展，確保孕產婦心理健康護理成為標準服務，並作為產科護理的組成部分納入其中。

數位和遠端醫療解決方案的進步正在徹底改變孕產婦心理健康服務的獲取方式，尤其是在偏遠和醫療資源匱乏的地區，並成為推動該領域發展的另一個強勁動力。行動應用程式、線上諮詢平台和遠端患者監護等技術進步直接解決了地域限制和人員短缺的問題，從而能夠更快地提供幫助。 Startup Nation Central 於 2026 年 1 月發布的《2026 年心理健康技術地圖》印證了這一趨勢，該地圖顯示，到 2025 年，整個心理健康技術行業的資金籌措將達到 3.52 億美元，同比成長 150%。這表明人們對適用於孕產婦保健的擴充性模式越來越感興趣。資金的激增正在推動便利高效的數位工具的開發，這些工具能夠提高患者的便利性，並透過提供私人醫療服務來減少社會歧視。正如加拿大福利協會 (Benefits Canada) 在 2025 年 8 月舉行的「2025 年心理健康高峰會」上所報告的那樣，鑑於未得到治療的孕產婦心理健康問題估計每年給加拿大經濟造成 110 億加元的損失，這項技術進步至關重要。

市場挑戰

全球孕產婦心理健康專業人員持續短缺，是全球孕產婦心理健康市場擴張的主要障礙。這種短缺直接阻礙了孕產婦獲得及時有效的治療，進而阻礙了必要的診斷、治療和支持系統的廣泛應用和發展。訓練有素的專業人員數量不足最終會減緩市場發展，因為很大一部分目標人群無法方便地獲得這些急需的服務。

人力資源限制導致醫療服務提供有顯著差異。正如孕產婦心理健康政策中心在2025年指出的那樣，美國84%的周產期人口生活在孕產婦心理健康服務提供者不足的地區。這種普遍存在的短缺凸顯了專業人員的匱乏如何直接阻礙市場覆蓋和醫療服務提供，從而限制了用於治療孕產婦心理健康障礙的基本治療方法的收入前景和推廣。

市場趨勢

數位療法（DTx）的興起和整合正透過提供擴充性且有科學依據的治療方法，顯著影響全球孕產婦心理健康市場。這些以軟體為基礎的工具為產後憂鬱症問題提供系統性治療，並大大改善了那些難以獲得傳統面對面醫療服務的患者就醫的途徑。有利的法規結構和透明支付管道的建立進一步加速了這一市場發展勢頭。例如，一份於2024年12月發布的題為《孕產婦心理健康數位療法是否已準備好進入黃金時代？ 》的報告指出，美國醫療保險和醫療補助服務中心（CMS）在擬議的2025年醫療保健醫師報銷計劃中引入了三個新的通用醫療程序代碼（HCPCS）索賠代碼。這些代碼將於2025年1月1日生效，適用於獲得FDA核准的數位心理健康設備，並正在創建一個有助於該領域更廣泛接受的報銷體系。

另一個正在改變孕產婦心理健康市場的關鍵趨勢是將行為健康服務更直接融入產科護理。透過將心理健康篩檢、評估和治療納入常規的產前和產後檢查，此策略有助於及早發現和治療心理健康問題。這種無縫整合解決了醫療保健服務碎片化的難題，降低了就醫障礙，並確保心理健康支持成為孕產婦整體護理的標配。孕產婦心理健康政策中心於2026年1月發布的《2025年影響報告》透過分析41個州的醫療補助管理式醫療機構（MCO）契約，重點闡述了這一轉變。報告指出，目前已有9個州強制要求或獎勵產科醫師透過篩檢、經濟獎勵或HEDIS®報告等方式管理孕產婦心理健康。這代表著一項正在加速發展（儘管尚處於起步階段）的監管舉措，旨在支持建立全面統一的護理框架。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球孕產婦心理健康市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 疾病特定類別（產後憂鬱症、低落性情感疾患、妊娠期及產後整體焦慮症、妊娠期及產後強迫症、與分娩相關的創傷後壓力症候群、其他）
  • 治療方法（人際關係療法、抗憂鬱症、認知行為療法等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美孕產婦心理健康市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲孕產婦心理健康市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區孕產婦心理健康市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲孕產婦心理健康市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲孕產婦心理健康市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球孕產婦心理健康市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Therapy Mama
• Canopie Inc
• Pfizer Inc
• Viatris Inc.
• GSK plc
• Alembic Pharmaceuticals Limited
• Keenova Therapeutics plc
• Saphire, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Maternal Mental Health Market is anticipated to expand from USD 5.97 billion in 2025 to USD 10.57 billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.99%. This market includes a wide variety of diagnostics, treatments, and support services designed to prevent, detect, and manage mental health issues throughout pregnancy and the postpartum phase. Growth is primarily fueled by rising awareness of perinatal mental health among the public and healthcare professionals, deeper recognition of how maternal health affects child development, and the increasing worldwide incidence of postpartum depression and anxiety. For context, the World Health Organization reported in 2023 that about 10% of expectant mothers and 13% of recent mothers worldwide suffer from a mental health condition, with depression being the most common.

A major hurdle that may slow market expansion is the ongoing worldwide shortage of dedicated maternal mental health experts, especially in disadvantaged areas. This deficit in skilled personnel limits patients' ability to receive prompt and suitable treatment, which could in turn hinder the widespread rollout and utilization of essential mental health services and interventions.

Market Driver

State funding and favorable regulations are strongly driving the global maternal mental health market by building specific infrastructure and increasing access to services. These public sector efforts frequently result in direct financial support, which facilitates the growth of crucial treatment networks. For example, the Royal College of Midwives noted that in February 2025, £36.5 million was designated to enhance family mental health support in England, originating from a broader £126 million state funding increase for the 2025-2026 period. These investments enable the creation and expansion of specialized perinatal mental health programs, professional training, and routine screening initiatives. Furthermore, policies stimulate market advancement by requiring insurance benefits and encouraging integrated care frameworks, ensuring that maternal mental health is treated as a standard, reimbursable element of comprehensive maternity care.

Progress in digital and telehealth solutions acts as another powerful growth catalyst by revolutionizing access to maternal mental health care, especially in remote or disadvantaged regions. Technological breakthroughs like mobile apps, online counseling platforms, and remote patient monitoring tackle geographic limitations and staff shortages directly, facilitating quicker assistance. Highlighting this trend, Startup Nation Central's "2026 Mental Health Technology Map" from January 2026 revealed that funding for the general mental health tech industry reached $352 million in 2025-a 150% jump from the prior year-signaling intensified interest in scalable models suitable for maternal care. This capital surge aids the creation of accessible, efficient digital tools that improve patient convenience and lower stigma through private care options. This technological evolution is vital given that untreated maternal mental health issues cost the Canadian economy an estimated $11 billion annually, as reported during Benefits Canada's 2025 Mental Health Summit in August 2025.

Market Challenge

The ongoing worldwide deficit of dedicated maternal mental health specialists stands as a major obstacle to the expansion of the global maternal mental health market. This lack of personnel directly curtails access to prompt and proper treatment, thereby stunting the broader implementation and growth of vital diagnostics, therapies, and support systems. Market progress is ultimately slowed because a large segment of the target demographic is unable to easily access these much-needed services due to an inadequate supply of trained professionals.

These human resource constraints lead to massive gaps in care delivery. As highlighted by the Policy Center for Maternal Mental Health in 2025, 84% of the perinatal demographic in the United States lived in regions experiencing a shortage of maternal mental health providers. Such pervasive scarcities emphasize that a lack of available specialists directly suppresses market reach and care execution, consequently limiting the revenue prospects and the distribution of essential treatments meant to combat perinatal mental health conditions.

Market Trends

The rise and integration of digital therapeutics (DTx) are heavily shaping the global maternal mental health market by providing expandable, scientifically backed treatments. These software-based tools deliver structured therapy for issues such as postpartum depression, greatly improving access for patients who encounter obstacles to conventional in-person care. This market momentum is further accelerated by favorable regulatory frameworks and the establishment of transparent payment channels. For instance, a December 2024 publication titled "Are Maternal Mental Health Digital Therapeutics Ready for Prime Time?" noted that the Centers for Medicare and Medicaid Services (CMS) rolled out three new Healthcare Common Procedure Coding System billing codes in its Proposed 2025 Medicare Physician Fee Schedule. Taking effect on January 1, 2025, these codes are tailored for FDA-approved digital mental health devices, creating a reimbursement structure that promotes wider industry acceptance.

Another crucial trend transforming the maternal mental health market is the growing incorporation of behavioral health services directly into obstetrics. By embedding mental health screenings, evaluations, and treatments into routine prenatal and postpartum visits, this strategy promotes much earlier identification and care. This seamless integration combats fragmented healthcare and lowers barriers to entry, ensuring that mental health support becomes a standard part of overall maternal treatment. The Policy Center for Maternal Mental Health's "2025 Impact Report," published in January 2026, highlighted this shift by analyzing 41 state Medicaid Managed Care Organization contracts; it found that nine states currently mandate or reward obstetricians for managing maternal mental health via screenings, financial incentives, or HEDIS(R) reporting. This demonstrates an early yet accelerating regulatory movement favoring holistic, unified care frameworks.

Key Market Players

• Therapy Mama
• Canopie Inc
• Pfizer Inc
• Viatris Inc.
• GSK plc
• Alembic Pharmaceuticals Limited
• Keenova Therapeutics plc
• Saphire, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

Report Scope

In this report, the Global Maternal Mental Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Maternal Mental Health Market, By Disease Indication

• Postpartum Depression
• Dysthymia
• Pregnancy and Postpartum General Anxiety
• Pregnancy and Postpartum OCD
• Birth-Related PTSD
• Others

Maternal Mental Health Market, By Therapy

• Interpersonal Psychotherapy
• Antidepressants
• Cognitive Behavioral Therapy
• others

Maternal Mental Health Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Maternal Mental Health Market.

Available Customizations:

Global Maternal Mental Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Maternal Mental Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others)
  • 5.2.2. By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Maternal Mental Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Indication
  • 6.2.2. By Therapy
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Maternal Mental Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Indication
      • 6.3.1.2.2. By Therapy
  • 6.3.2. Canada Maternal Mental Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Indication
      • 6.3.2.2.2. By Therapy
  • 6.3.3. Mexico Maternal Mental Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Indication
      • 6.3.3.2.2. By Therapy

7. Europe Maternal Mental Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Indication
  • 7.2.2. By Therapy
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Maternal Mental Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Indication
      • 7.3.1.2.2. By Therapy
  • 7.3.2. France Maternal Mental Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Indication
      • 7.3.2.2.2. By Therapy
  • 7.3.3. United Kingdom Maternal Mental Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Disease Indication
      • 7.3.3.2.2. By Therapy
  • 7.3.4. Italy Maternal Mental Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Indication
      • 7.3.4.2.2. By Therapy
  • 7.3.5. Spain Maternal Mental Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Indication
      • 7.3.5.2.2. By Therapy

8. Asia Pacific Maternal Mental Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Indication
  • 8.2.2. By Therapy
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Maternal Mental Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Indication
      • 8.3.1.2.2. By Therapy
  • 8.3.2. India Maternal Mental Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Indication
      • 8.3.2.2.2. By Therapy
  • 8.3.3. Japan Maternal Mental Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Indication
      • 8.3.3.2.2. By Therapy
  • 8.3.4. South Korea Maternal Mental Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Indication
      • 8.3.4.2.2. By Therapy
  • 8.3.5. Australia Maternal Mental Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Indication
      • 8.3.5.2.2. By Therapy

9. Middle East & Africa Maternal Mental Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Indication
  • 9.2.2. By Therapy
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Maternal Mental Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Indication
      • 9.3.1.2.2. By Therapy
  • 9.3.2. UAE Maternal Mental Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Indication
      • 9.3.2.2.2. By Therapy
  • 9.3.3. South Africa Maternal Mental Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Indication
      • 9.3.3.2.2. By Therapy

10. South America Maternal Mental Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Indication
  • 10.2.2. By Therapy
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Maternal Mental Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Indication
      • 10.3.1.2.2. By Therapy
  • 10.3.2. Colombia Maternal Mental Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Indication
      • 10.3.2.2.2. By Therapy
  • 10.3.3. Argentina Maternal Mental Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Indication
      • 10.3.3.2.2. By Therapy

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Maternal Mental Health Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Therapy Mama
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Canopie Inc
• 15.3. Pfizer Inc
• 15.4. Viatris Inc.
• 15.5. GSK plc
• 15.6. Alembic Pharmaceuticals Limited
• 15.7. Keenova Therapeutics plc
• 15.8. Saphire, Inc.
• 15.9. Bausch Health Companies Inc.
• 15.10. Magellan Health, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer